| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |